Fresh Tracks Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fresh Tracks Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Fresh Tracks Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2023 was -58.8 %, a 65.1% increase year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Return On Equity for 2023 was -58.8 %, a 65.1% increase from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Return On Equity for 2022 was -168 %, a 2.83% decline from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Return On Equity for 2021 was -164 %, a 40.3% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -58.8 +110 +65.1% Jan 1, 2023 Dec 31, 2023
2022 -168 -4.63 -2.83% Jan 1, 2022 Dec 31, 2022
2021 -164 -47.1 -40.3% Jan 1, 2021 Dec 31, 2021
2020 -117 -205 -232% Jan 1, 2020 Dec 31, 2020
2019 88.2 +74.1 +527% Jan 1, 2019 Dec 31, 2019
2018 14.1 +100 Jan 1, 2018 Dec 31, 2018
2017 -86.1 -66.1 -329% Jan 1, 2017 Dec 31, 2017
2016 -20.1 -0.58 -2.98% Jan 1, 2016 Dec 31, 2016
2015 -19.5 +10.1 +34.1% Jan 1, 2015 Dec 31, 2015
2014 -29.6 +15.5 +34.4% Jan 1, 2014 Dec 31, 2014
2013 -45.1 -22 -95.7% Jan 1, 2013 Dec 31, 2013
2012 -23 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.